Post

The FDA just approved daraxonrasib, a breakthrough drug for advanced pancreatic cancer that doubles survival time. This is huge: pancreatic cancer was once thought untreatable. The researchers received a standing ovation when they presented the trial results, unheard of at scientific conferences.

Patrick Laverty

@patricklaverty.com

This is great. I wish there was an option for the research company to submit their receipts, get paid back by the gov't for all their research to get to this point and then they charge something reasonable for the pills themselves, instead of a half million dollars a year.

26/8/26, 7:59 pm0 reposts2 likes

No replies yet.